Article Information
History
- February 15, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- A. Lawrence Gould1,*,
- Robert K. Campbell2,
- John W. Loewy3,
- Robert A. Beckman4,
- Jyotirmoy Dey5,
- Anja Schiel6,
- Carl-Fredrik Burman7,
- Joey Zhou8,
- Zoran Antonijevic9,
- Eva R. Miller10 and
- Rui Tang11
- 1Methodology Research, BARDS, Merck & Co., Inc., Kenilworth NJ, USA
- 2Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence RI
- 3DataForethought, Winchester, MA, USA
- 4Lombardi Comprehensive Cancer Center and Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA
- 5Data and Statistical Sciences, AbbVie, North Chicago, IL, USA
- 6Department for Pharmacoeconomics, Norwegian Medicines Agency, Oslo, Norway
- 7Data Science & AI, AstraZeneca R&D, Gothenburg, Sweden
- 8Xcovery Pharmaceuticals, Palm Beach Gardens, FL, USA
- 9Abond CRO, Allendale, MI, USA
- 10Independent Biostatistical Consultant, Middletown Twp, PA, USA
- 11Methodology and Data Visualization, Biostatistics Department, Servier Pharmaceuticals US
- ↵*Corresponding Author: A. Lawrence Gould, goulda{at}merck.com (ALG)
Posted February 15, 2022.
